Grass City 20% OFF

Marapharm Ventures Inc. (OTCQB:MRPHF) (CNSX:MDM-CN.CN) (FSE:2M0) (MDM.CN) (“Marapharm” or the ” Company”) ( was given notice by the Nevada Department of Taxation of conditional approval for 2 additional distributor licenses for its cultivation and production facilities in Las Vegas, Nevada. Marapharm now has 3 conditional distributor licenses.

“We are thrilled to receive these conditional approvals. These licenses will be key to allowing us to distribute product beginning early next year from our planned expansive 380,000 square foot cultivation and production facility. With these approvals in addition to the acquisition of the specialized vehicles needed, we can ensure we get product to market quickly and safely,” Linda Sampson, Marapharm CEO.

These approvals follow quickly on the heels of the August, 2017 conditional approval of Marapharm’s first application for a marijuana distributor license. The conditions to be met are the inspection of vehicles and of the facility.


Marapharm is a publicly traded company on the Canadian Stock Exchange (CSE: MDM, OTCQB: MRPHF) primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include production locations in the key North American states of Washington, Nevada, and California. They actively seek expansion opportunities worldwide.





Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, in Europe, ticker symbol 2M0 on the FSE.

Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.


Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.

FOR FURTHER INFORMATION: or Linda Sampson, CEO 778-583-4476 email

View original content:

SOURCE Marapharm Ventures Inc.